Conditions Treated
Our Approach to Hybrid Surgical-Catheter Ablation
If you have persistent atrial fibrillation (AFib), a type of abnormal heart rate, medications and repeated treatment may not control your symptoms. At Stanford, our heart experts are among the first in the country to develop a hybrid surgical-catheter approach to treat persistent AFib.
Electrophysiologists (specialists in conditions that affect the heart’s electrical system) and heart surgeons in our Arrhythmia Center work together to treat the heart from both inside and out. This innovative, collaborative approach provides better long-term outcomes and improves your quality of life.
WHAT WE OFFER FOR HYBRID SURGICAL-CATHETER ABLATION
- Leading role in developing hybrid surgical-catheter ablation, a new treatment option for hard-to-treat AFib that targets tissue both inside and outside the heart.
- Team-based treatment planning to bring together electrophysiologists, heart surgeons, and doctors from other heart specialties to tailor a care plan to your needs.
- Access to ongoing clinical trials for eligible patients; our arrhythmia experts and heart surgeons are collaborating in this research.
To request an appointment with one of our arrhythmia specialists, call: 650-723-6459.